Our Track Record

In the past 25 years, ChemDiv, Inc. had a privilege to collaborate with industrial partners in Pharma and BioTech sector, as well as with not-for-profit organizations including Academia, Foundations and Screening Centers all over the World. Reflective of current trends in modern drug discovery, we offer very competitive, timely and professional services in all key areas of Chemistry, Biology and Clinical Sciences.

Our project teams are engaged on every stage of modern drug discovery starting with protein production, in vitro/ex vivo assay development and execution, focused library selection, medicinal chemistry, structure-based drug design and finishing with advanced in vivo studies, IND package preparation and clinical trials. We have successfully delivered custom services and advanced molecules in the areas of oncology, CNS-, inflammatory disorders and virology.

Our flexible business models are reflective of a personalized approach to all valued partners. FTE-, project- , success-based interactive modes or their combination are designed to match your scientific, financial and timing needs. Whether we work with a virtual organization or a large client, process flow is built on rigorous metrics that includes well defined deliverables, timelines, milestones and GO/NO-GO decisions.

ChemDiv's Partners include

 

astrazeneca bayer biogen
du pont genentech lilly
solvay novartis merck
nerviano novo-nordisk sanofi
schering takeda tanabe